Literature DB >> 26378411

Epidemiology, Prognostic Factors, and Treatment of Malignant Submandibular Gland Tumors: A Population-Based Cohort Analysis.

Robert J Lee, Andrew P Tan, Elizabeth L Tong, Nihal Satyadev, Russell E Christensen.   

Abstract

IMPORTANCE: Malignant tumors of the submandibular gland are uncommon, leading to limited information regarding prognostic factors and difficulty in evaluating treatment modalities.
OBJECTIVE: To investigate the correlates of survival in patients with primary malignant tumors of the submandibular gland. DESIGN, SETTING, AND PARTICIPANTS: Data from 2626 patients with a diagnosis of primary tumors of the submandibular gland between 1973 and 2011 in the Surveillance, Epidemiology, and End Results database were used in a retrospective population-based cohort analysis. Kaplan-Meier analysis along with multivariate Cox regression analysis was performed to determine prognostic factors in overall survival (OS) and disease-specific survival (DSS).
INTERVENTIONS: Patients were treated with surgery, radiation therapy, both, or neither. MAIN OUTCOMES AND MEASURES: Overall and disease-specific survival.
RESULTS: We identified 2626 patients with a diagnosis of primary malignant tumors of the submandibular gland, 52.9% male and 47.1% female, with a mean (range) age of 61.3 (7-101) years. Adenoid cystic carcinoma (36.0%) was the most prevalent histologic subtype, followed by squamous cell carcinoma (18.1%), mucoepidermoid carcinoma (16.9%), and adenocarcinoma (13.7%). Kaplan-Meier analysis demonstrated an OS and DSS of 65% and 74%at 2 years, 54% and 67% at 5 years, and 40% and 60% at 10 years, respectively. Multivariate Cox regression analysis revealed independent predictors of OS and DSS to be age (HR, 1.04 [95% CI, 1.03-1.04], P < .001; HR, 1.02 [95% CI, 1.01-1.03], P < .001), sex (HR, 0.69 [95% CI, 0.57-0.84], P < .001; HR, 0.73 [95% CI, 0.56-0.96], P = .02), tumor grade (HR, 1.47 [95% CI, 1.19-1.81], P < .001; HR, 1.67 [95% CI, 1.25-2.25], P = .001), stage at presentation (HR, 1.56 [95% CI, 1.41-1.72], P < .001; HR, 1.96 [95% CI, 1.69-2.28], P < .001), and surgical resection (HR, 0.55 [95% CI, 0.41-0.74], P < .001; HR, 0.51 [95% CI, 0.35-0.75], P = .001). CONCLUSIONS AND RELEVANCE: We report, to our knowledge, the largest study to date focused on correlates of survival in submandibular gland malignant neoplasms. Multivariate analysis found that older age at diagnosis, high tumor grade, and later stage at presentation were correlated with decreased survival whereas female sex and surgical resection were correlated with increased survival. In addition, a 3-cm tumor cutoff size was demonstrated above which was associated with a significantly less favorable prognosis. Radiation therapy had mixed association with survival, dependent on tumor size and subtype.

Entities:  

Mesh:

Year:  2015        PMID: 26378411     DOI: 10.1001/jamaoto.2015.1745

Source DB:  PubMed          Journal:  JAMA Otolaryngol Head Neck Surg        ISSN: 2168-6181            Impact factor:   6.223


  7 in total

1.  Primary intraosseous mucoepidermoid carcinoma of the mandible: radiographic evolution and clinicopathological features.

Authors:  Nicholas B Abt; Matthew E Lawler; Joseph Zacharias; Edward T Lahey
Journal:  BMJ Case Rep       Date:  2019-04-03

2.  Application of the Milan System for Reporting Submandibular Gland Cytopathology: An international, multi-institutional study.

Authors:  Zahra Maleki; Zubair Baloch; Ryan Lu; Khurram Shafique; Sharon J Song; Kartik Viswanathan; Rema A Rao; Holly Lefler; Aisha Fatima; Austin Wiles; Vickie Y Jo; He Wang; Guido Fadda; Celeste N Powers; Syed Z Ali; Liron Pantanowitz; Momin T Siddiqui; Ritu Nayar; Jerzy Klijanienko; Guliz A Barkan; Jeffrey F Krane; Esther D Rossi; Fabiano Callegari; Ivana Kholová; Massimo Bongiovanni; William C Faquin; Marc P Pusztaszeri
Journal:  Cancer Cytopathol       Date:  2019-05-03       Impact factor: 5.284

3.  Prediction of malignancy of submandibular gland tumors with apparent diffusion coefficient.

Authors:  Ahmed Abdel Khalek Abdel Razek
Journal:  Oral Radiol       Date:  2017-12-29       Impact factor: 1.852

Review 4.  Diagnostic Utility of Radiomics in Thyroid and Head and Neck Cancers.

Authors:  Maryam Gul; Kimberley-Jane C Bonjoc; David Gorlin; Chi Wah Wong; Amirah Salem; Vincent La; Aleksandr Filippov; Abbas Chaudhry; Muhammad H Imam; Ammar A Chaudhry
Journal:  Front Oncol       Date:  2021-07-07       Impact factor: 6.244

Review 5.  Adenoid cystic carcinoma: emerging role of translocations and gene fusions.

Authors:  Piotr T Wysocki; Evgeny Izumchenko; Juliet Meir; Patrick K Ha; David Sidransky; Mariana Brait
Journal:  Oncotarget       Date:  2016-10-04

Review 6.  Genomics of mucoepidermoid and adenoid cystic carcinomas.

Authors:  Kenneth Yan; Jessica Yesensky; Rifat Hasina; Nishant Agrawal
Journal:  Laryngoscope Investig Otolaryngol       Date:  2018-02-08

7.  The Role of Prognostic Factors in Salivary Gland Tumors Treated by Surgery and Adjuvant Radio- or Chemoradiotherapy - A Single Institution Experience.

Authors:  Izabela Kordzińska-Cisek; Paweł Cisek; Ludmiła Grzybowska-Szatkowska
Journal:  Cancer Manag Res       Date:  2020-02-11       Impact factor: 3.989

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.